Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.

Dickerson EB, Bryan BA.

Vet Sci. 2015 Sep 21;2(3):270-292. doi: 10.3390/vetsci2030270. Review.

2.

Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors.

Tschida BR, Temiz NA, Kuka TP, Lee LA, Riordan JD, Tierrablanca CA, Hullsiek R, Wagner S, Hudson WA, Linden MA, Amin K, Beckmann PJ, Heuer RA, Sarver AL, Yang JD, Roberts LR, Nadeau JH, Dupuy AJ, Keng VW, Largaespada DA.

Cancer Res. 2017 Dec 1;77(23):6576-6588. doi: 10.1158/0008-5472.CAN-17-2281. Epub 2017 Oct 9.

PMID:
28993411
3.

β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy.

Bucsek MJ, Qiao G, MacDonald CR, Giridharan T, Evans L, Niedzwecki B, Liu H, Kokolus KM, Eng JW, Messmer MN, Attwood K, Abrams SI, Hylander BL, Repasky EA.

Cancer Res. 2017 Oct 15;77(20):5639-5651. doi: 10.1158/0008-5472.CAN-17-0546. Epub 2017 Aug 17.

PMID:
28819022
4.

Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1603-1610. doi: 10.1158/1055-9965.EPI-17-0346. Epub 2017 Aug 14.

PMID:
28807926
5.

Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.

Weberpals J, Jansen L, Haefeli WE, Hoffmeister M, Wolkewitz M, Herk-Sukel MPPV, Vissers PAJ, Brenner H.

Sci Rep. 2017 Jun 6;7(1):2911. doi: 10.1038/s41598-017-02913-8.

6.

Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.

Garg J, Feng YX, Jansen SR, Friedrich J, Lezoualc'h F, Schmidt M, Wieland T.

Oncotarget. 2017 Jul 4;8(27):44732-44748. doi: 10.18632/oncotarget.17267.

7.

Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.

Shaashua L, Shabat-Simon M, Haldar R, Matzner P, Zmora O, Shabtai M, Sharon E, Allweis T, Barshack I, Hayman L, Arevalo J, Ma J, Horowitz M, Cole S, Ben-Eliyahu S.

Clin Cancer Res. 2017 Aug 15;23(16):4651-4661. doi: 10.1158/1078-0432.CCR-17-0152. Epub 2017 May 10.

PMID:
28490464
8.
9.

Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells.

Harris DA, Park JM, Lee KS, Xu C, Stella N, Hague C.

J Pharmacol Exp Ther. 2017 May;361(2):219-228. doi: 10.1124/jpet.116.237255. Epub 2017 Feb 14.

PMID:
28196836
10.

Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.

Hung YH, Huang HL, Chen WC, Yen MC, Cho CY, Weng TY, Wang CY, Chen YL, Chen LT, Lai MD.

Oncol Rep. 2017 Feb;37(2):969-978. doi: 10.3892/or.2016.5334. Epub 2016 Dec 23.

PMID:
28035420
11.

Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.

Cardwell CR, Pottegård A, Vaes E, Garmo H, Murray LJ, Brown C, Vissers PA, O'Rorke M, Visvanathan K, Cronin-Fenton D, De Schutter H, Lambe M, Powe DG, van Herk-Sukel MP, Gavin A, Friis S, Sharp L, Bennett K.

Breast Cancer Res. 2016 Dec 1;18(1):119.

12.

Schwann cells: a new player in the tumor microenvironment.

Bunimovich YL, Keskinov AA, Shurin GV, Shurin MR.

Cancer Immunol Immunother. 2017 Aug;66(8):959-968. doi: 10.1007/s00262-016-1929-z. Epub 2016 Nov 24. Review.

13.

Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer.

Modzelewska B, Jóźwik M, Jóźwik M, Sulkowski S, Pędzińska-Betiuk A, Kleszczewski T, Kostrzewska A.

J Physiol Sci. 2017 Nov;67(6):711-722. doi: 10.1007/s12576-016-0500-1. Epub 2016 Nov 12.

14.

Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.

Jean Wrobel L, Bod L, Lengagne R, Kato M, Prévost-Blondel A, Le Gal FA.

Oncotarget. 2016 Nov 22;7(47):77825-77837. doi: 10.18632/oncotarget.12833.

15.

Attractor landscape analysis of colorectal tumorigenesis and its reversion.

Cho SH, Park SM, Lee HS, Lee HY, Cho KH.

BMC Syst Biol. 2016 Oct 20;10(1):96.

16.

Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation.

Min HY, Boo HJ, Lee HJ, Jang HJ, Yun HJ, Hwang SJ, Smith JK, Lee HJ, Lee HY.

Oncotarget. 2016 Oct 25;7(43):70936-70947. doi: 10.18632/oncotarget.12342.

17.

Association of Ovarian Tumor β2-Adrenergic Receptor Status with Ovarian Cancer Risk Factors and Survival.

Huang T, Tworoger SS, Hecht JL, Rice MS, Sood AK, Kubzansky LD, Poole EM.

Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1587-1594. Epub 2016 Sep 1.

18.

β-Adrenergic-stimulated macrophages: Comprehensive localization in the M1-M2 spectrum.

Lamkin DM, Ho HY, Ong TH, Kawanishi CK, Stoffers VL, Ahlawat N, Ma JCY, Arevalo JMG, Cole SW, Sloan EK.

Brain Behav Immun. 2016 Oct;57:338-346. doi: 10.1016/j.bbi.2016.07.162. Epub 2016 Jul 30.

19.

Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.

Birmann BM, Barnard ME, Bertrand KA, Bao Y, Crous-Bou M, Wolpin BM, De Vivo I, Tworoger SS.

Am J Public Health. 2016 Sep;106(9):1608-15. doi: 10.2105/AJPH.2016.303337. Epub 2016 Jul 26. Review.

20.

Octopamine connects nutrient cues to lipid metabolism upon nutrient deprivation.

Tao J, Ma YC, Yang ZS, Zou CG, Zhang KQ.

Sci Adv. 2016 May 6;2(5):e1501372. doi: 10.1126/sciadv.1501372. eCollection 2016 May.

Supplemental Content

Support Center